Document ID: chunk:federal_register_of_legislation:F2024L01521:clause:1_18
Version: federal_register_of_legislation:F2024L01521
Segment Type: clause
Provision Reference: sch 1 cl 18
Character Range: 8938–10361

18  Schedule 1 (table)
After:
Galantamine  Capsule (prolonged release) 8 mg (as hydrobromide)  Oral  Gamine XR  3 months stock by reference to usual demand

insert:
Glimepiride  Tablet 1 mg  Oral  ARX-GLIMEPIRIDE     6 months stock by reference to usual demand of both Glimepiride APOTEX and ARX-GLIMEPRIDE added together
Glimepiride  Tablet 1 mg  Oral  Glimepiride APOTEX  6 months stock by reference to usual demand of both Glimepiride APOTEX and ARX-GLIMEPRIDE added together
Glimepiride  Tablet 2 mg  Oral  ARX-GLIMEPIRIDE     6 months stock by reference to usual demand of both Glimepiride APOTEX and ARX-GLIMEPRIDE added together
Glimepiride  Tablet 2 mg  Oral  Glimepiride APOTEX  6 months stock by reference to usual demand of both Glimepiride APOTEX and ARX-GLIMEPRIDE added together
Glimepiride  Tablet 3 mg  Oral  ARX-GLIMEPIRIDE     6 months stock by reference to usual demand of both Glimepiride APOTEX and ARX-GLIMEPRIDE added together
Glimepiride  Tablet 3 mg  Oral  Glimepiride APOTEX  6 months stock by reference to usual demand of both Glimepiride APOTEX and ARX-GLIMEPRIDE added together
Glimepiride  Tablet 4 mg  Oral  ARX-GLIMEPIRIDE     6 months stock by reference to usual demand of both Glimepiride APOTEX and ARX-GLIMEPRIDE added together
Glimepiride  Tablet 4 mg  Oral  Glimepiride APOTEX  6 months stock by reference to usual demand of both Glimepiride APOTEX and ARX-GLIMEPRIDE added together